Menopausal hormone therapy prior to the diagnosis of ovarian cancer is associated with improved survival

Prior studies of menopausal hormone therapy (MHT) and ovarian cancer survival have been limited by lack of hormone regimen detail and insufficient sample sizes. To address these limitations, a comprehensive analysis of 6419 post-menopausal women with pathologically confirmed ovarian carcinoma was conducted to examine the association between MHT use prior to diagnosis and survival.Data from 15 studies in the Ovarian Cancer Association Consortium...